Clinical Trial Update: Targeting Inflammation in Acute Coronary Syndrome Using Colchicine [Phase 2, Phase 3]

View source ↗

Summary

The document reports the completion of Phase 2 and Phase 3 trials evaluating colchicine for inflammation in Acute Coronary Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Acute Coronary Syndrome | Phase 2, Phase 3 | Status: COMPLETED